Dr. Mark J. Dannenbaum, MD

Dr. Dannenbaum practices at Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System.

Dr. Dannenbaum's NPI, 1275700924, was assigned on May 13, 2008. Dr. Dannenbaum graduated from McGovern Medical School in 2002. Dr. Dannenbaum's Texas license number on file is N6245.

Dr. Dannenbaum's primary practice is Memorial Hermann-Texas Medical Center, at 6411 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 704-3700.

Dr. Dannenbaum's primary practice is Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System. Dr. Dannenbaum is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UTHealth Houston Neurosciences, Texas Medical Center. Dmand AI also links Dr. Dannenbaum to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dannenbaum practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Dannenbaum's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Dannenbaum is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Dannenbaum's licenses on file in 3 states: Texas, Georgia and Massachusetts.

Dmand AI lists craniotomy among the conditions Dr. Dannenbaum treats.

CMS data shows 85 Medicare services from Dr. Dannenbaum across 2 procedure codes in 2024, all of them office visits, for 85 Medicare patients. Medicare paid $6,308 for them. Every service was in an office.

CMS counts 85 Medicare patients who saw Dr. Dannenbaum in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dannenbaum's median patient age at 65, with 46% women.

In 2024, Dr. Dannenbaum wrote 49 Medicare Part D claims for 11 patients. 100% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $193 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Dannenbaum for performance year 2024, reported as part of a group. Dr. Dannenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dannenbaum as offering telehealth.

Dmand AI links 32 papers to Dr. Dannenbaum, published from 2011 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Subarachnoid Hemorrhage, Tomography, X-Ray Computed and Brain Ischemia. Dr. Dannenbaum has published most often in Stroke. Dr. Dannenbaum's most frequent co-authors are Spiros Lee Blackburn, MD, Peng Roc Chen, MD and Arthur L. Day, MD.

CMS Open Payments shows 73 general payments to Dr. Dannenbaum from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Medtronic, Inc. paid the most, $950.

Dr. Dannenbaum graduated from McGovern Medical School in 2002. Dr. Dannenbaum is a member of CNS.

Dr. Dannenbaum is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.